←Back to list

Neuralink

Creating a generalized brain interface to restore autonomy to those with unmet medical needs today and unlock human potential tomorrow
Neuralink develops implantable brain-computer interfaces that translate neural signals into digital actions, enabling people with paralysis to control computers and robotic devices with their thoughts. The company serves patients with severe neurological conditions including paralysis, blindness, and speech impairment. Neuralink represents a critical breakthrough in neurotechnology with FDA breakthrough designations for multiple devices and growing human clinical trials.
Health 📍 Fremont, California Founded 2016
Current Valuation
$15B
as of 2025-Q2
DECACORN

QL Price

$9.0B
0% vs last round
QuantLogix's current estimate for Neuralink, published 2026-10-07 — in line with the last disclosed round of $9.0B (2026-08).
Confidence
low
Basis
round anchored
What backs this price
Last disclosed round $9.0B 2026-08 weight 0.88
How this price has held up
No round has priced for Neuralink since QuantLogix began publishing a price for it, so there is nothing to grade yet. The claim above is on the record from 2026-10-07 and will be graded against the next priced round. See the full accuracy record →
How to actually get exposure to Neuralink →
Which publicly-traded funds already hold it, what $10,000 buys, and whether any route is open to you.
Cite this price as QuantLogix QL Price, Neuralink, 2026-10-07 (e8ec57a43600feb4). The id pins this exact claim, so a citation stays checkable after the price moves. Model estimate for research — not a quote, target price, or investment advice.

IPO Outlookprivate

Is Neuralink going public?
No. Neuralink is private and has not filed to go public. There is no S-1 on file.
What is Neuralink's valuation in 2026?
Neuralink is valued at $15B as of 2025-Q2, set by its Series E ($650M, Jun 2025). That is the last confirmed mark, not a live price — private shares do not trade continuously.
Has Neuralink filed an S-1?
No public S-1 is on file for Neuralink.
Who are Neuralink's investors?
Neuralink's investors include ARK Invest, Founders Fund, Sequoia Capital, Thrive Capital, DFJ Growth, G42 and 5 more.
How much has Neuralink raised?
Neuralink has raised $1.3B in total, most recently a Series E of $650M in Jun 2025.
Is Neuralink publicly traded — can you buy Neuralink stock?
No. Neuralink is a private company — its shares are not listed on any exchange and there is no ticker. The routes to exposure are pre-IPO secondary marketplaces and funds (accredited investors), employee tender offers when the company runs one, and public companies with read-through exposure. QuantLogix maps every route it can verify for Neuralink on its Pre-IPO Access Desk.
How to actually get exposure to Neuralink →
Answers are derived from the roster record shown on this page — filing status, last round and confirmed marks. Where the record is silent, the answer says so rather than guessing.

Company Profile

CEO
Jared Birchall
Founded
2016
HQ
Fremont, California
Employees
~600
Total Raised
$1.3B
Growth
pre-revenue, scaling to $1B by 2031
Last Round
Series E — $650M (Jun 2025)
IPO Status
none

Fundraising Status

Series E · $650M · 1y 4mo ago
noneTotal raised $1.3B

Latest Funding Round

RoundAmountDateLead InvestorPost-Money
Series E$650MJun 2025——

Vertical Intelligence — Biotech / Gene Therapy

Registered trials
6
6 active · 5 recruiting
Focus areas
Tetraplegia/Tetraparesis
Quadriplegia · Quadriplegia/Tetraplegia
Latest trial start
2025-10-03
Name-verified against lead sponsor "Neuralink Corp" on ClinicalTrials.gov as of 2026-10-04. Verify on ClinicalTrials.gov ↗

Talent Signal

Hiring trend
▶ Hiring steady
+1% vs 2026-08
Open roles
79
via greenhouse
Product-build share
76%
engineering, research, product, design
Trajectory
steady
heavy product build — 76% of open roles are product-building functions (engineering/research/product) — 27 of 79 open roles are engineering.
Actively hiring with no tracked executive churn.
Open roles by month
Open roles by month78Aug '2679Sep '26
Open roles by function
Open roles by functionEngineering27Hardware22Other15Design7Ops & People2Data & ML2Legal & Policy1Research1Clinical & Science1
■ product-building   ■ go-to-market / G&A
Analog and Mixed-Signal IC Design Engineer Intern Analog IC Design and Verification EngineerAnalog IC Layout EngineerBiomedical Engineer InternClinical ScientistDigital IC Design Engineer
Counted from Neuralink's live job board as of 2026-09-15; role functions classified from posting titles. Open-role counts are an activity signal, not headcount. Refreshed monthly.

Founders & Key People

Elon MuskMax HodakBenjamin RapoportDongjin SeoPaul MerollaPhilip SabesTimothy J. GardnerTim HansonVanessa Tolosa

Investors

ARK Invest · Founders Fund · Sequoia Capital · Thrive Capital · DFJ Growth · G42 · Human Capital · Lightspeed · QIA · Valor Equity Partners · Vy Capital

Products

  • Telepathy brain-computer interface
  • Blindsight visual prosthesis
  • N1 Link implantable brain chip
  • R1 Robot surgical system
  • Neuralink Application software
  • PRIME Study clinical trial program

Competitors

Synchron · Paradromics · Precision Neuroscience · Blackrock Neurotech · Science Corporation
Brain-Computer InterfaceMedical DeviceNeurotechnologyDeep Tech
Private-company numbers are not real-time. Reflects publicly disclosed valuations from press releases, news reports, and tender offers as of 2025-Q2. Refreshed quarterly.